Long-Term Safety and Effectiveness of Adalimumab for Moderate to Severe Psoriasis: Results from 7-Year Interim Analysis of the ESPRIT Registry
Titel:
Long-Term Safety and Effectiveness of Adalimumab for Moderate to Severe Psoriasis: Results from 7-Year Interim Analysis of the ESPRIT Registry
Auteur:
Menter, Alan Thaçi, Diamant Wu, Jashin J. Abramovits, William Kerdel, Francisco Arikan, Dilek Guo, Dianlin Ganguli, Arijit Bereswill, Mareike Camez, Anne Valdecantos, Wendell C.